News — Commit Biologics

News

Categories:

June 10 – 2024

Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics

May 9 – 2024

Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease

February 14 – 2024

Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

August 28 – 2023

Commit Biologics appoints Krishna Polu as Chief Executive Officer

June 28 – 2023

Publication describing the BiCE technology featured in Journal of Immunology

Publication Research Technology

February 8 – 2023

Anker Lundemose is appointed chairman of the board

August 8 – 2022

Commit Biologics is participating in the Synapse BioBusiness Summer School 2022

April 12 – 2022

Commit Biologics attending the BioEquity, Milan 2022

January 25 – 2022

Commit Biologics attending the BioSeed, London 2022

October 18 – 2021

Commit Biologics gets accepted into the Venture Lab program at the BioInnovation Institute

Funding Research

For inquiries please contact us
at info@commitbio.com

Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark

+45 3049 7099
LinkedIn

© 2022 Commit Biologics. All rights reserved.

CB_Brandmark_Light-Green